A fifth U.S. Ebola patient was flown out of Africa on Monday to receive treatment in the U.S. The man, Ashoka Mukpo, 33, became ill last week while working as a freelance cameraman for NBC News. He will start treatment in an isolation unit in Nebraska as Thomas Eric Duncan, the first person to develop symptoms after returning from West Africa to the U.S., takes a turn for the worse. Health officials said Duncan did not appear to be receiving experimental drugs. Supplies of one, ZMapp, were "all gone." Read more at Reuters.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Continue reading for free
We hope you're enjoying The Week's refreshingly open-minded journalism.
Subscribed to The Week? Register your account with the same email as your subscription.
-
Today's political cartoons - December 4, 2023Cartoons Monday's cartoons - funding for Ukraine, trials for Tesla, and more
-
Prince Harry back in court: a guide to the Duke of Sussex's latest legal battles
The Explainer The 'most litigious' royal currently involved in cases against three major publishers as well as the Home Office
-
Covid inquiry: the most important questions for Boris Johnson
Talking Point Former PM has faced weeks of heavy criticism from former colleagues at the public hearing
-
US life expectancy rose in 2022 but not to pre-pandemic levels
Speed Read Life expectancy is slowly crawling back up
-
Vallance diaries: Boris Johnson 'bamboozled' by Covid science
Speed Read Then PM struggled to get his head around key terms and stats, chief scientific advisor claims
-
An increasing number of dog owners are 'vaccine hesitant' about rabies
Speed Read A new survey points to canine vaccine hesitancy
-
Anger may be a powerful motivator for tough goals, new study suggests
Speed Read Keeping your cool might actually be less efficient than letting your anger drive you
-
A tropical skin disease is making the rounds in the US
Speed Read Leishmaniasis is endemic to the country and can cause ulcers and disfiguration
-
FDA moves to ban menthol cigarettes
Speed Read It's been a long time coming
-
How viruses can help fight antibiotic-resistant infections
Speed Read So-called phage therapy could be the next big thing
-
Popular weight loss drugs linked to higher risk of serious gastrointestinal problems
Speed Reads Researchers found that semaglutide, the active ingredient in Wegovy and Ozempic, had a higher risk for side effects like stomach paralysis.
